Akèy › Kansè tete negatif triple › New York › Rochester
Etid klinik pou Kansè tete negatif triple nan Rochester, NY
3 etid pou Kansè tete negatif triple ap chèche patisipan nan sit nan ak bò kote Rochester (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Ap rekriteFaz 3
- Lipson Cancer Institute - Linden Oaks, Rochester
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Ap rekriteFaz 2
- University of Rochester Wilmot Cancer Institute, Rochester
Access to Genetic Testing in Underserved Patients With Cancer
Ap rekriteVolontè an sante akeyi
- University of Rochester, Rochester
Etid Kansè tete negatif triple nan lòt vil
- Houston, TX42 etid
- New York City, NY31 etid
- Nashville, TN28 etid
- Los Angeles, CA27 etid
- Boston, MA26 etid
- San Antonio, TX23 etid
- St. Louis, MO21 etid
- Arlington, VA20 etid
- Atlanta, GA20 etid
- Dallas, TX18 etid
- Chicago, IL16 etid
- Columbus, OH16 etid
Lòt etid nan Rochester
- Leksemi mieloïd egi16 etid
- Kansè poumon15 etid
- Kansè nan tete15 etid
- Kansè (tout kalite)14 etid
- Obèsite14 etid
- Sipwa13 etid
- Kansè Poumon ki pa ti selil13 etid
- Kansè pwostat10 etid
- Kansè Metastatik8 etid
- Myelom Miltip8 etid
- Kansè vejik7 etid
- Distrofi myotonik7 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.